|
|
Blood, 15 September 2004, Vol. 104, No. 6, pp. 1816-1824.
Prepublished online as a Blood First Edition Paper on May 25, 2004; DOI 10.1182/blood-2004-01-0395.
 Previous Article | Table of Contents | Next Article 
NEOPLASIA
Cholesterol synthesis and import contribute to protective cholesterol increments in acute myeloid leukemia cells
Deborah E. Banker,
Sasha J. Mayer,
Henry Y. Li,
Cheryl L. Willman,
Frederick R. Appelbaum, and
Richard A. Zager
From the Fred Hutchinson Cancer Research Center, Seattle, WA; and University of New Mexico Cancer Research Facility, Albuquerque, NM.
Cholesterol levels are abnormally increased in many acute myeloid leukemia (AML) samples exposed in vitro to chemotherapy. Blocking these acute cholesterol responses selectively sensitizes AML cells to therapeutics. Thus, defining the molecular mechanisms by which AML cells accomplish these protective cholesterol increments might elucidate novel therapeutic targets. We now report that the levels of mRNAs encoding the cholesterol synthesis-regulating enzyme, 3-hydroxy-3-methylglutaryl coenzyme A reductase, and the cholesterol-importing low-density lipoprotein (LDL) receptor were both increased by daunorubicin (DNR) or cytarabine (ARA-C) treatments in almost three fourths of cultured AML samples. However, less than one third of AML samples significantly increased LDL accumulation during drug treatments, suggesting that de novo synthesis is the primary mechanism by which most AML cells increase cholesterol levels during drug exposures. LDL increments were not correlated with cholesterol increments in ARA-C–treated AML samples. However, LDL and cholesterol increments did correlate in DNR-treated AML samples where they were measured, suggesting that a subset of AMLs may rely on increased LDL accumulation during treatment with particular drugs. Our data suggest that cholesterol synthesis inhibitors may improve the efficacy of standard antileukemia regimens, but that for maximum benefit, therapy may need to be tailored for individual patients with leukemia.
 CiteULike  Connotea  Del.icio.us  Digg  Reddit  Technorati What's this?
Related Article in Blood Online:
-
Reducing cholesterol and overcoming drug resistance
- Steven Grant
Blood 2004 104: 1598-1599.
[Full Text]
[PDF]
This article has been cited by other articles:
|
|
|
|
 
K. van der Weide, S. D.P.W.M. de Jonge-Peeters, F. Kuipers, E. G.E. de Vries, and E. Vellenga
Combining Simvastatin with the Farnesyltransferase Inhibitor Tipifarnib Results in an Enhanced Cytotoxic Effect in a Subset of Primary CD34+ Acute Myeloid Leukemia Samples
Clin. Cancer Res.,
May 1, 2009;
15(9):
3076 - 3083.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
A. Sassano, M. Lo Iacono, G. Antico, A. Jordan, S. Uddin, R. A. Calogero, and L. C. Platanias
Regulation of leukemic cell differentiation and retinoid-induced gene expression by statins
Mol. Cancer Ther.,
March 1, 2009;
8(3):
615 - 625.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
M. Naito, K. Bomsztyk, and R. A. Zager
Renal Ischemia-Induced Cholesterol Loading: Transcription Factor Recruitment and Chromatin Remodeling along the HMG CoA Reductase Gene
Am. J. Pathol.,
January 1, 2009;
174(1):
54 - 62.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
A. Sassano, E. Katsoulidis, G. Antico, J. K. Altman, A. J. Redig, S. Minucci, M. S. Tallman, and L. C. Platanias
Suppressive Effects of Statins on Acute Promyelocytic Leukemia Cells
Cancer Res.,
May 1, 2007;
67(9):
4524 - 4532.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
C. C. Sanchez-Martin, A. Davalos, C. Martin-Sanchez, G. de la Pena, C. Fernandez-Hernando, and M. A. Lasuncion
Cholesterol Starvation Induces Differentiation of Human Leukemia HL-60 Cells
Cancer Res.,
April 1, 2007;
67(7):
3379 - 3386.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
S. M. Kornblau, D. E. Banker, D. Stirewalt, D. Shen, E. Lemker, S. Verstovsek, Z. Estrov, S. Faderl, J. Cortes, M. Beran, et al.
Blockade of adaptive defensive changes in cholesterol uptake and synthesis in AML by the addition of pravastatin to idarubicin + high-dose Ara-C: a phase 1 study
Blood,
April 1, 2007;
109(7):
2999 - 3006.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
